J-Pharma
PublicJ-Pharma is now publicly traded
The data on this page reflects J-Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series F
Jul 7, 2025
Total Funding Raised
$73.89M
Company Overview
J-Pharma is a biotechnology company that specializes in the research and development of novel drugs targeting SLC transporters, particularly L-type amino acid transporter 1 (LAT1), for the treatment of cancer and autoimmune diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
J-Pharma Comparables
Compare J-Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 74% | |
| Aetas Pharma Co., Ltd. | 51% |
J-Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Jul 7, 2025 | ||||
| Grant | Apr 1, 2025 | ||||
| Series E Extension | Apr 1, 2025 | ||||
| Series E | Oct 5, 2023 | ||||
| Series D | Jul 30, 2020 |
J-Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| QR Investment Co., Ltd. | Series E |
| Tokai Tokyo Investment Co., Ltd. | Series E Extension |
| F-Prime Capital | Series E |
| 日本ベンチャーキャピタル株式会社 | Series D |
| 株式会社FFGベンチャービジネスパートナーズ | Series E Extension |
| JIC Venture Growth Investments | Series E Extension |
J-Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access